Mar 12, 2026 08:32AM Celularity reaffirms NEXGEL partnership for biomaterials commercialization

Mar 10, 2026 08:31AM Celularity secures $35 million licensing deal for biomaterials portfolio

Feb 10, 2026 08:31AM Celularity receives $12.2 million from New Jersey tax credit sale

Dec 31, 2025 04:18PM Celularity (CELU) files for 14.08M share offering by selling stockholders

Dec 26, 2025 08:31AM Celularity CEO comments on Medicare skin substitute rule withdrawal

Dec 22, 2025 04:01PM Celularity closes $10 million financing with former DoubleLine executive

Dec 19, 2025 04:17PM Celularity (CELU) files for 15.95M share offering by selling stockholders

Dec 18, 2025 02:10PM Celularity secures up to $12 million in binding financing agreements

Dec 5, 2025 04:40PM Celularity receives FDA warning letter over Interfyl marketing claims

Oct 30, 2025 08:03AM Celularity partners with DefEYE for eye care biologics licensing deal

Sep 9, 2025 07:35AM WBB Securities Upgrades Celularity (CELU) to Buy

Aug 18, 2025 08:52AM WBB Securities Starts Celularity (CELU) at Speculative Buy

Aug 18, 2025 08:03AM Celularity retires $41.6 million senior secured debt through IP sale

Jun 10, 2025 04:15PM Celularity (CELU) Announces CFO Transition

Feb 24, 2025 08:01AM Celularity (CELU) Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

Feb 13, 2025 06:25AM Celularity (CELU) Files for 4.63M Share and Warrant Offering

Dec 10, 2024 08:01AM Celularity (CELU) Announces Resolution of Nasdaq Listing Compliance Matter

Nov 27, 2024 05:01PM Celularity (CELU) Receives Nasdaq Non-compliance Notice

Oct 22, 2024 08:31AM Celularity (CELU) Provides Corporate Update

Oct 16, 2024 05:15PM Celularity (CELU) Acquires Rebound Product from Sequence LifeScience

Aug 28, 2024 04:49PM Celularity (CELU) Appoints Richard J. Berman to its Board